Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New site-directed nanoparticle delivery system useful to treat ocular inflammation in vivo

Jan. 3, 2008

ISTA submits NDA to FDA for Xibrom for inflammation, pain and photophobia

Dec. 27, 2007

Novel therapeutic agents for glaucoma reported in recent Allergan patents

Dec. 14, 2007

Silencing mTOR useful in experimental proliferative vitreoretinopathy

Dec. 11, 2007

InSite Vision files new drug submission with Health Canada for AzaSite for conjunctivitis

Dec. 5, 2007

FDA approves Alcon's Triesence for use in eye surgery

Dec. 3, 2007

Fovea and Genzyme Corporation enter research collaboration in ophthalmology

Nov. 29, 2007

Preclinical data show multiple mechanisms of action for sonepcizumab

Nov. 16, 2007

Lantibio and TRB Chemedica enter licensing agreement with Alcon for dry eye drug

Nov. 12, 2007

Recent Allergan patent describes novel antiglaucoma agents

Nov. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.